bioAffinity Technologies, Inc. Debt Instrument, Interest Rate, Stated Percentage
bioAffinity Technologies, Inc. (BIAF) had Debt Instrument, Interest Rate, Stated Percentage of 6.70% as of 2025-09-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2026-08-07
- 2025-09-30: Debt Instrument, Interest Rate, Stated Percentage 6.70%.
- 2024-09-30: Debt Instrument, Interest Rate, Stated Percentage 11.64%; Debt Instrument, Interest Rate, Stated Percentage as first filed 6.70%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage | Debt Instrument, Interest Rate, Stated Percentage as first filed |
|---|---|---|
| 2025-09-30 | 6.70% 10-Q · filed 2026-08-07 | |
| 2024-09-30 | 11.64% 10-Q · filed 2025-11-14 | 6.70% 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |